AAN 2021

MS disease-modifying therapies influence COVID-19 infection severity

Presented By

Dr Maria Pia Sormani, University of Genoa, Italy

Conference

AAN 2021

22 April, 2021 10:35

Duration and severity of chemosensory dysfunction following COVID-19 infection

Presented By

Nicholas Bussière, University of Quebec, Canada

Conference

AAN 2021

22 April, 2021 10:35

The role of brain ATP abnormalities in MS disease progression

Presented By

Dr Vijayshree Yadav, Oregon Health & Science University, USA

Conference

AAN 2021

22 April, 2021 10:35

COVID-19 pandemic results in decreased global stroke care

Presented By

Dr Thanh Ngoc Nguyen, Boston University School of Medicine, Massachusetts, USA

Conference

AAN 2021

22 April, 2021 10:35

Long-term survival outcomes of AMX0035 for ALS

Presented By

Dr Sabrina Paganoni, Massachusetts General Hospital, USA

Trial

Phase 2, CENTAUR

Conference

AAN 2021

22 April, 2021 10:35

Long-term follow-up outcomes of deep brain stimulation in Parkinson disease

Presented By

Dr Jill Ostrem (University of California, USA) & Dr Jerrold Vitek (University of Minnesota, USA)

Conference

AAN 2021

20 April, 2021 10:37

Neurological symptoms in children with inflammatory syndrome following COVID-19

Presented By

Dr Omar Abdel-Mannan, University College London, UK

Conference

AAN 2021

20 April, 2021 10:37

Mast cell and neutrophil involvement in the disease activity of MS

Presented By

Dr Antonino Giordano, San Raffaele Scientific Institute, Milan, Italy

Conference

AAN 2021

20 April, 2021 10:37

Neurofilament light outperforms total tau as biomarker for neurodegeneration

Presented By

Dr Jordan Marks, Mayo Clinic, Minnesota, USA

Conference

AAN 2021

20 April, 2021 10:37

Obstructive sleep apnoea common in cognitively impaired population

Presented By

David Colelli, University of Toronto, Canada

Conference

AAN 2021

20 April, 2021 10:37

No effect of foetal antiseizure exposure on neurodevelopmental outcomes at age 3

Presented By

Prof. Kimford J. Meador, Stanford University, California, USA

Trial

MONEAD

Conference

AAN 2021

19 April, 2021 10:50

sNfL projects development of definite MS

Presented By

Prof. Jens Kuhle, University of Basel, Switzerland

Trial

Phase 3, REFLEX

Conference

AAN 2021

19 April, 2021 10:50

No link between antidepressants and intracerebral haemorrhage in stroke patients

Presented By

Dr Mithilesh Siddu, George Washington University, Washington DC, USA

Conference

AAN 2021

19 April, 2021 10:50

Long-term safety of atogepant as preventive treatment of migraine

Presented By

Prof. Messoud Ashina, University of Copenhagen, Denmark

Conference

AAN 2021

19 April, 2021 10:49

Cenobamate long-term efficacy and concentration reference range

Presented By

Dr Michael R. Sperling, Thomas Jefferson University, Pennsylvania, USA

Trial

YKP3089C013, YKP3089C017, YKP3089C021

Conference

AAN 2021

19 April, 2021 10:49